Skip to content

Racial Disparities in Antidepressant Treatment After a Psychiatric Consultation

Depression Disorders | Depression - Major Depressive Disorder

Patients from black, indigenous, and people of color (BIPOC) communities are reported to have lower rates of antidepressant adherence and response. The investigators have a limited understanding of why this disparity exists. The majority of outpatient psychiatric consultations are one-time assessments that provide treatment recommendations to the primary care provider. It is important to identify whether there are racial differences in accessing and adhering to recommended treatment plans to provide more equitable care. To the investigators' knowledge, there are no studies that examined racial differences in access and barriers to receiving antidepressant treatment after a one-time psychiatric assessment. This study focuses on patients who were diagnosed with major depressive disorder during a psychiatric consultation 3 months prior. We are examining whether there are racial differences in being a) recommended an antidepressant, b) started/switched to a recommended antidepressant, c) treated at a therapeutic dosage, d) adherence to treatment, and e) whether sociodemographic factors, discrimination in medical settings, and patient perception of depression and antidepressant treatment moderate these differences. This study will inform the development of treatment strategies that minimize racial disparities in the treatment of depression.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

1. Able and willing to sign and date the informed consent form
2. Stated willingness to comply with all study procedures
3. Age 18 years and older
4. Diagnosis of depression in a psychiatric consultation at CAMH in the last 3 months
5. Not currently followed by a psychiatrist
6. Able to complete the REDCap questionnaire in English using the internet

Exclusion Criteria:

1. Presence of a life-time diagnosis of bipolar disorder or schizophrenia
2. Potential participants with a suicidal plan or intent whose consulting psychiatrist determined are in need of immediate clinical attention (e.g., referral to CAMH ED, voluntary or involuntary hospitalization)
3. Acute psychosis (e.g., MDD with psychotic features)

Lieu de l'étude

Centre for Addiction and Mental Health
Centre for Addiction and Mental Health
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Benoit Mulsant

[email protected]
416-535-8501
Backup Contact

Dewi Clark

[email protected]
416-535-8501
Backup Contact

Benoit Mulsant

Étude parrainée par
Centre for Addiction and Mental Health
Participants recherchés
Plus d'informations
ID de l'étude: NCT06799078